Eagle Asset Management Inc Pacira Bio Sciences, Inc. Transaction History

Eagle Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$25.5 - $31.51 $14,254 - $17,614	-559 Reduced 0.42%	131,724 $3.77 Million
Q1 2024 May 09, 2024	SELL	$27.7 - $35.48 $47,560 - $60,919	-1,717 Reduced 1.28%	132,283 $3.87 Million
Q4 2023 Feb 12, 2024	SELL	$26.32 - $34.31 $62,983 - $82,103	-2,393 Reduced 1.75%	134,000 $4.52 Million
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $1.92 Million - $2.51 Million	62,597 Added 84.82%	136,393 $4.18 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $47.5 $2.67 Million - $3.51 Million	73,796 New	73,796 $2.96 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.